Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients
NCT ID: NCT00473980
Last Updated: 2012-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
28 participants
INTERVENTIONAL
1998-12-31
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer
NCT05220800
A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
NCT06378398
Time to Surgery - the Impact of Waiting Time on Outcome After Colorectal Cancer Treatment
NCT04571047
Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment Response
NCT04130971
Effects of Preoperative Correction of Anemia With Intravenously Iron in Colorectal Cancer Patients.
NCT05221957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Drug
Treatment with indomethacin or celecoxib
Indomethacin, celecoxib, esomeprazole
SHAM
Sham treatment
Indomethacin, celecoxib, esomeprazole
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indomethacin, celecoxib, esomeprazole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Göteborg University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kent Lundholm, MD, prof
Role: PRINCIPAL_INVESTIGATOR
Göteborg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Göteborg University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
kl4501122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.